Sponsor or institution

Clinical trials and research at Ausper Biopharma Co., Ltd.

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• AHB-137 injection in people with chronic hepatitis B

  This study tests AHB-137 vs placebo in adults with chronic hepatitis B who have not yet received antiviral treatment.

  Recruiting at 34 sites Phase 2 Ausper Biopharma Co., Ltd. · Beijing, Beijing Municipality and 33 other locations · NCT07635186

• AHB-171 in Chronic Hepatitis B patients

  This study tests whether AHB-171 injections are safe and effective in adults with chronic hepatitis B, including people who have never taken hepatitis B medicine and those who have prior NA treatment.

  Recruiting at 10 sites Phase 2 Ausper Biopharma Co., Ltd. · Beijing, Beijing Municipality and 9 other locations · NCT07630727

• AHB-137 injection pharmacokinetics and safety in people with mild to moderate liver dysfunction and normal liver function

  This study tests how AHB-137 behaves in the body and its safety in adults with chronic hepatitis B who have mild to moderate liver problems or normal liver function.

  Recruiting Phase 1 Ausper Biopharma Co., Ltd. · Chongqing, Chongqing Municipality and 4 other locations · NCT07600788

• AHB-171 injectable therapy in healthy adults and chronic hepatitis B patients

  This early test will see if AHB-171 is safe and tolerable in healthy adults and people with chronic hepatitis B, and whether the immune system responds to it.

  Recruiting at 2 sites Phase 1 Ausper Biopharma Co., Ltd. · Ch’ang-ch’un, Jilin and 1 other locations · NCT07511218

• Long-term follow-up of people with chronic hepatitis B after AHB-137 injection

  This follow-up will see how long viral control lasts in people with chronic hepatitis B who had a complete or partial response to AHB-137 injection.

  Recruiting at 8 sites Ausper Biopharma Co., Ltd. · Hefei, Anhui and 36 other locations · NCT07146100

• AHB-137 injection for adults with chronic hepatitis B previously treated with nucleos(t)ide analogue antivirals

  This will test whether AHB-137 injection improves viral control and liver function in adults with chronic hepatitis B who were previously treated with nucleos(t)ide analogue antivirals.

  Recruiting at 4 sites Phase 2 Ausper Biopharma Co., Ltd. · Beijing, Beijing Municipality and 11 other locations · NCT07137910

• AHB-137 in combination with hepatitis B drugs for chronic hepatitis B

  This phase 2 study tests whether AHB-137 given with other HBV medicines can help people with chronic hepatitis B who are already on antiviral therapy.

  Recruiting at 14 sites Phase 2 Ausper Biopharma Co., Ltd. · Beijing, Beijing Municipality and 13 other locations · NCT07069569

Quick answers

How many clinical trials run by Ausper Biopharma Co., Ltd. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →